Global Biohacking Market Size & Outlook, 2021-2028

The biohacking industry worldwide is expected to reach a projected revenue of US$ 63,719.6 billion by 2028. A compound annual growth rate of 19.4% is expected of the worldwide biohacking industry from 2022 to 2028.
Revenue, 2021 (US$B)
$18,417.9
Forecast, 2028 (US$B)
$63,719.6
CAGR, 2022 - 2028
19.4%
Report Coverage
Worldwide

Global biohacking market highlights

  • The global biohacking market generated a revenue of USD 18,417.9 billion in 2021 and is expected to reach USD 63,719.6 billion by 2028.
  • The market is expected to grow at a CAGR (2022 - 2028) of 19.4% by 2028.
  • In terms of segment, wearables accounted for a revenue of USD 3,311.0 billion in 2021.
  • Smart Drugs is the most lucrative product segment registering the fastest growth during the forecast period.
  • In terms of region, North America was the largest revenue generating market in 2021.
  • Country-wise, Spain is expected to register the highest CAGR from 2022 to 2028.

Global data book summary

Market revenue in 2021USD 18,417.9 billion
Market revenue in 2028USD 63,719.6 billion
Growth rate19.4% (CAGR from 2021 to 2028)
Largest segmentWearables
Fastest growing segmentSmart Drugs
Historical data covered2018 - 2020
Base year for estimation2021
Forecast period covered2022 - 2028
Quantitative unitsRevenue in USD billion
Market segmentationWearables, Implants (Chips), Gene Modification Kits, Smart Drugs, Supplements, Mobile Apps

Other key industry trends

  • In terms of revenue, the North America accounted for 36.9% of the global biohacking market in 2021.
  • By country, the U.S. is projected to lead the global market in terms of revenue in 2028.
  • By country, Spain is the fastest growing regional market and is projected to reach USD 1,025.8 billion by 2028.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Biohacking Market Companies

Name Profile # Employees HQ Website

Global biohacking market outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to biohacking market will help companies and investors design strategic landscapes.


Wearables was the largest segment with a revenue share of 17.98% in 2021. Horizon Databook has segmented the Global biohacking market based on wearables, implants (chips), gene modification kits, smart drugs, supplements, mobile apps covering the revenue growth of each sub-segment from 2018 to 2028.


  • Global Biohacking Product Outlook (Revenue, USD BIllion, 2018-2028)
    • Wearables
    • Implants (Chips)
    • Gene Modification Kits
    • Smart Drugs
    • Supplements
    • Mobile Apps
    • Others
  • Global Biohacking Application Outlook (Revenue, USD BIllion, 2018-2028)
    • Monitoring
    • Treatment
    • Research
    • Others
  • Global Biohacking End User Outlook (Revenue, USD BIllion, 2018-2028)
    • Pharmaceutical & Biotechnology Companies
    • Hospitals & Clinics
    • Forensic Laboratories
    • Research & Academic Institutes
    • Others

Reasons to subscribe to Global biohacking market databook:

  • Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
  • Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
  • Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
  • Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
  • Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of Global biohacking market databook

  • Our clientele includes a mix of biohacking market companies, investment firms, advisory firms & academic institutions.
  • 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
  • Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
  • The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of global-level data and insights on the Global biohacking market , including forecasts for subscribers. This global databook contains high-level insights into Global biohacking market from 2018 to 2028, including revenue numbers, major trends, and company profiles.

Partial client list

  • logo

Global biohacking market size, by region, 2018-2028 (US$B)

Top 10 countries: Biohacking market size, 2021 (US$B)

Global biohacking market share, by product, 2021 & 2028 (%, US$B)

Biohacking market: Opportunity assessment by country

Global biohacking market, by region, 2021 (US$B)

Global biohacking market size, by region, 2018-2028 (US$B)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more